Cancer: New Inhibitor Effective Where Other Treatments Fail
Investigation of targeted treatment in refractory myeloma patients: scientists from Karl Landsteiner University of Health Sciences part of team behind international study. Krems (Austria), 3. December...
View ArticlePsychological intervention study: even brief abstinence from social media...
Researchers from Karl Landsteiner University of Health Sciences identify addiction-like behaviour after time away from social media Krems (Austria), 14 November 2018 – In many cases, just a seven-day...
View ArticleHealth centres for the homeless: evaluation requires trust
The findings of an international study have now been published by the Austrian Ludwig Boltzmann Institute for Health Technology Assessment Vienna, (Austria) 11 April 2019 – Trust is a vital factor...
View ArticleMake Your Own Template . This provides you the flexibility to
Creating a layout in Canva frequently entails picking from our premade themes. Nonetheless, you’re cost-free to develop your own layouts without utilizing a make your own template . This provides you...
View ArticleMarinosolv technology successfully used in preclinical study in severe eye...
Marinosolv®identified as a feasible aqueous drug carrier with distinct advantages in eye drops Manifold scope of application for Marinosolv®confirmed Vienna (Austria), February 6th, 2020.Marinomed...
View ArticleDonor Organs on Demand: Research Looks at Lifelike Organ Models Produced on...
Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models Krems, 02 October 2018 – A research project recently initiated...
View ArticleEurope and USA: agreement on definition and diagnosis of specific form of...
Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process Krems (Austria), 6 November 2018 – A transcontinental agreement was recently reached on...
View ArticleMarinomed extends the range of Marinosolv applications
• Preclinical studies show promising results with new compounds like mometasone, fluticasone and fluorometholone • Potential for developments in allergy, asthma, and ophthalmology • Marinosolv®...
View ArticleClinical Results of Neurodegenerative Study
AFFiRiS Announces Results of a Phase I Clinical Study Using AFFITOPEs® PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients...
View ArticleOn the “shelf life” of water: Hot on the trail of the biostability of water...
Karl Landsteiner University of Health Sciences in Krems launches project to study the growth of water-based microorganisms Krems (Austria), 9 August 2018 – In order to better understand and assess the...
View ArticleDonor Organs on Demand: Research Looks at Lifelike Organ Models Produced on...
Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models Krems, 02 October 2018 – A research project recently initiated...
View ArticleMarinomed with record sales in 2019 and positive outlook for 2020
Covid-19 will sustainably change in dealing with viral infections of the respiratory tractStrong demand for Carragelose®productsMarinosolv®technology extended to further areas of application31% sales...
View ArticleCancer Immunotherapy Can Cause Heart Muscle Damage
Doctors at Karl Landsteiner University of Health Sciences in Krems (Austria) review data on immune reactions in heart muscle inflammation. Krems (Austria), 16. April 2020 – Immunotherapy is a powerful...
View ArticleViravaxx AG and the Medical University of Vienna have launched a project for...
Vienna (Austria), 21 April, 2020. Viravaxx AG, a clinical stage biopharmaceutical company based in Vienna, Austria, announced today that it has launched a project for combating COVID-19 together with...
View ArticleMarinomed receives FFG funding to research SARS-CoV-2 therapy based on...
Development of a Carragelose®-containing inhalation solution for therapy of patients suffering from a SARS-CoV-2 infectionAvailable clinical data show that Carragelose®binds previously known...
View ArticleClik here to view.
Donor Organs on Demand: Research Looks at Lifelike Organ Models Produced on...
Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models Krems, 02 October 2018 – A research project recently initiated...
View ArticleClik here to view.
Europe and USA: agreement on definition and diagnosis of specific form of...
Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process Krems (Austria), 6 November 2018 – A transcontinental agreement was recently reached on...
View ArticleOpportunity NOx. New Pilot System for Smart Adsorption of Nitrogen Oxide From...
Successful test in large city shows technology’s potential to avert car bans; installation in vehicle exhaust systems the ultimate goal Pasching (Austria) 13th May 2020.A specially developed...
View ArticleBrain metastases. Does fluorescent marking facilitate the surgical removal of...
Physicians from Karl Landsteiner University of Health Sciences in Krems (KL Krems, Austria) present results of the world’s most extensive study headed by the MedUni Vienna investigating the value of...
View ArticleMarinomed expands into Italy and broadens its portfolio
Carragelose®products available in Italy as of autumn 2020New decongestant nasal spray Carravin set for market launch in AustriaMarinomed extends product pipeline for Marinosolv® and Carragelose®...
View Article